Table 3 Laboratory parameters of subjects with bronchiectasis with and without cardiovascular disease
From: Clinical impact of cardiovascular disease on patients with bronchiectasis
|  | Bronchiectasis (n = 404) | Bronchiectasis with cardiovascular disease (n = 199) | P-value |
|---|---|---|---|
WBC, ×109 cells/L | 8.40 ± 5.03 | 8.82 ± 4.11 | 0.551 |
Neutrophils, % | 72.59 ± 12.05 | 75.48 ± 10.10 | 0.003 |
Haemoglobin, g/L | 123.05 ± 19.74 | 125.56 ± 22.44 | 0.329 |
Platelet, ×109 cells/L | 196.89 ± 83.96 | 195.24 ± 88.47 | 0.480 |
CRP, IU/mL | 28.53 ± 44.69 | 29.89 ± 38.82 | 0.168 |
ESR, mm/h | 41.07 ± 29.18 | 36.03 ± 30.61 | 0.168 |
Albumin, mg/dL | 37.90 ± 5.09 | 36.86 ± 4.28 | 0.095 |
K+, mmol/L | 3.98 ± 0.47 | 4.05 ± 0.61 | 0.009 |
Na+, mmol/L | 140.18 ± 4.51 | 139.52 ± 4.30 | 0.468 |
Cl−, mmol/L | 99.41 ± 5.23 | 96.09 ± 7.10 | 0.001 |
Ca+, mmol/L | 2.22 ± 0.36 | 2.20 ± 0.14 | 0.697 |
BUN, mol/L | 5.55 ± 3.35 | 6.04 ± 3.36 | 0.069 |
Blood glucose, mmol/L | 6.23 ± 2.47 | 6.56 ± 2.58 | 0.062 |
BNP, pg/L | 1365.22 ± 2996.11 | 3602.01 ± 6297.81 | < 0.001 |
Cholesterol, mol/L | 4.09 ± 0.97 | 4.16 ± 1.84 | 0.171 |
Triglyceride, mol/L | 1.16 ± 0.67 | 1.13 ± 0.60 | 0.772 |
D-dimer, mg/L | 0.69 ± 1.105 | 1.00 ± 1.676 | < 0.001 |
PO2, kPa | 10.11 ± 3.20 | 10.26 ± 3.50 | 0.018 |
PCO2, kPa | 6.59 ± 1.69 | 7.34 ± 1.83 | 0.02 |
SO2, % | 92.95 ± 7.55 | 92.19 ± 7.15 | 0.271 |